Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fengkai Li

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
International Journal of Molecular Sciences|April 5, 2020
Tumor Milieu Controlled by RB Tumor SuppressorShunsuke Kitajima, Fengkai Li, Chiaki Takahashi
Cells|May 5, 2021
Cancer Stem Cells and NeovascularizationFengkai Li, Jiahui Xu, Suling Liu
IEEE Transactions on Neural Networks and Learning Systems|October 31, 2025
Spectral Embedding Representation Based on Random Anchor Graph AggregationJie Zhou, Fengkai Li, Can Gao, et al.
Stem Cells (Dayton, Ohio)|February 20, 2015
Undifferentiated State Induced by Rb-p53 Double Inactivation in Mouse Thyroid Neuroendocrine Cells and Embryonic FibroblastsShunsuke Kitajima, Susumu Kohno, Atsushi Kondoh, et al.
Signal Transduction and Targeted Therapy|March 1, 2023
PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathwayRui Zhang, Mengxue Dong, Juchuanli Tu, et al.
Journal for Immunotherapy of Cancer|May 25, 2022
Ccl3 enhances docetaxel chemosensitivity in breast cancer by triggering proinflammatory macrophage polarizationDandan Sheng, Wei Ma, Rui Zhang, et al.
Communications Biology|January 18, 2023
The germline factor DDX4 contributes to the chemoresistance of small cell lung cancer cellsChristopher Noyes, Shunsuke Kitajima, Fengkai Li, et al.
Cancer Research|June 14, 2019
Retinoblastoma Inactivation Induces a Protumoral Microenvironment via Enhanced CCL2 SecretionFengkai Li, Shunsuke Kitajima, Susumu Kohno, et al.
Oncotarget|January 19, 2017
MicroRNA-140 mediates RB tumor suppressor function to control stem cell-like activity through interleukin-6Akiyo Yoshida, Shunsuke Kitajima, Fengkai Li, et al.
Cancer Research|April 24, 2024
IL1R2 Blockade Alleviates Immunosuppression and Potentiates Anti-PD-1 Efficacy in Triple-Negative Breast CancerJie Xia, Lixing Zhang, Xilei Peng, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
International Journal of Molecular Sciences|April 5, 2020
Tumor Milieu Controlled by RB Tumor SuppressorShunsuke Kitajima, Fengkai Li, Chiaki Takahashi
Cells|May 5, 2021
Cancer Stem Cells and NeovascularizationFengkai Li, Jiahui Xu, Suling Liu
IEEE Transactions on Neural Networks and Learning Systems|October 31, 2025
Spectral Embedding Representation Based on Random Anchor Graph AggregationJie Zhou, Fengkai Li, Can Gao, et al.
Stem Cells (Dayton, Ohio)|February 20, 2015
Undifferentiated State Induced by Rb-p53 Double Inactivation in Mouse Thyroid Neuroendocrine Cells and Embryonic FibroblastsShunsuke Kitajima, Susumu Kohno, Atsushi Kondoh, et al.
Signal Transduction and Targeted Therapy|March 1, 2023
PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathwayRui Zhang, Mengxue Dong, Juchuanli Tu, et al.
Journal for Immunotherapy of Cancer|May 25, 2022
Ccl3 enhances docetaxel chemosensitivity in breast cancer by triggering proinflammatory macrophage polarizationDandan Sheng, Wei Ma, Rui Zhang, et al.
Communications Biology|January 18, 2023
The germline factor DDX4 contributes to the chemoresistance of small cell lung cancer cellsChristopher Noyes, Shunsuke Kitajima, Fengkai Li, et al.
Cancer Research|June 14, 2019
Retinoblastoma Inactivation Induces a Protumoral Microenvironment via Enhanced CCL2 SecretionFengkai Li, Shunsuke Kitajima, Susumu Kohno, et al.
Oncotarget|January 19, 2017
MicroRNA-140 mediates RB tumor suppressor function to control stem cell-like activity through interleukin-6Akiyo Yoshida, Shunsuke Kitajima, Fengkai Li, et al.
Cancer Research|April 24, 2024
IL1R2 Blockade Alleviates Immunosuppression and Potentiates Anti-PD-1 Efficacy in Triple-Negative Breast CancerJie Xia, Lixing Zhang, Xilei Peng, et al.
Pageof 2